Edible Antibodies Halt E. Coli in Pigs, Could Help End Overuse of Antibiotics

According to a publication at BioPortfolio, Belgian researchers are developing an orally-administered antibody medication for patients living with gastrointestinal disorders. In most cases, antibodies are injected into the bloodstream for…

Continue Reading Edible Antibodies Halt E. Coli in Pigs, Could Help End Overuse of Antibiotics
Muscular Dystrophy Association to Host First Annual Combined Conference
Hundreds of people living with narcolepsy gathered at the NN's 2015 Conference to make friends and learn something new. Source: Narcolepsy Network

Muscular Dystrophy Association to Host First Annual Combined Conference

A recent publication from Charcot-Marie-Tooth News announced that this year, for the first time ever, the Muscular Dystrophy Association will be hosting its annual clinical conferences at the same event…

Continue Reading Muscular Dystrophy Association to Host First Annual Combined Conference
Gene Therapy Displays Potential for Treating Charcot-Marie-Tooth Disease 4 Subtype C
Kapa65 / Pixabay

Gene Therapy Displays Potential for Treating Charcot-Marie-Tooth Disease 4 Subtype C

According to a story from Charcot-Marie-Tooth News, early preliminary testing of a possible gene therapy treatment for a certain type of Charcot-Marie-Tooth disease showed potential in a mouse model. This…

Continue Reading Gene Therapy Displays Potential for Treating Charcot-Marie-Tooth Disease 4 Subtype C
AMO Pharma Presents New Rating Scale for Type 1 Myotonic Dystrophy Symptoms
jarmoluk / Pixabay

AMO Pharma Presents New Rating Scale for Type 1 Myotonic Dystrophy Symptoms

A press release from American biopharmaceutical company AMO Pharma, published by PR Newswire, detailed the recent completion of the Company's new congenital myotonic dystrophy type 1 (CDM1) symptom-evaluation scale. The…

Continue Reading AMO Pharma Presents New Rating Scale for Type 1 Myotonic Dystrophy Symptoms